{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T05:27:38Z","timestamp":1738387658304,"version":"3.35.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1,31]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Associations of autoimmune diseases are rare but interesting and challenging situations from a diagnostic, pathophysiological, and therapeutic point of view. This article studies a rare association of autoimmune diseases by discussing the pathophysiological hypotheses and an original therapeutic management. The coexistence of antineutrophil cytoplasmic antibody-associated vasculitis and spondyloarthritis has rarely been described.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We present a patient with inflammatory back pain, stiffness, and enthesopathies followed by pulmonary and ear, nose and throat granulomatous involvement.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>A combination of spondyloarthritis and granulomatosis with polyangiitis, with spinal, enthesopathic, pulmonary, and ear, nose and throat involvement.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions and outcomes:<\/jats:title>\n            <jats:p>Effective treatment with rituximab both on spondyloarthritis and vasculitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>We discuss the pathogenic, diagnostic, and therapeutic implications of this rare but intriguing association between these 2 inflammatory conditions.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000041366","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T20:01:16Z","timestamp":1738353676000},"page":"e41366","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Rare association of granulomatosis with polyangiitis with an underdiagnosed spondyloarthritis effectively treated with rituximab: A case-report"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4060-4365","authenticated-orcid":false,"given":"Thomas","family":"Escoda","sequence":"first","affiliation":[{"name":"Service de M\u00e9decine Interne, H\u00f4pital Europ\u00e9en, Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie","family":"Dehaene","sequence":"additional","affiliation":[{"name":"Service de Radiologie, H\u00f4pital Europ\u00e9en, Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laetitia","family":"Velardocchio","sequence":"additional","affiliation":[{"name":"Service de Pneumologie, H\u00f4pital Europ\u00e9en, Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnaud","family":"Deveze","sequence":"additional","affiliation":[{"name":"Service d\u2019Oto-Rhino-Laryngologie, Chirurgie de la Face et du Cou, Clinique Clairval, Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Terrier","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, H\u00f4pital Cochin, Paris, France."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Chiche","sequence":"additional","affiliation":[{"name":"Service de M\u00e9decine Interne, H\u00f4pital Europ\u00e9en, Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised International Chapel Hill consensus conference nomenclature of vasculitides.","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R2-20250131","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41572-020-0204-y","article-title":"ANCA-associated vasculitis.","volume":"6","author":"Kitching","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"R3-20250131","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5152\/eujrheum.2022.20248","article-title":"Updates in ANCA-associated vasculitis.","volume":"9","author":"Ross","year":"2022","journal-title":"Eur J Rheumatol"},{"key":"R4-20250131","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10067-018-4212-1","article-title":"Prevalence of overlap of antineutrophil cytoplasmic antibody associated vasculitis with systemic autoimmune diseases: an unrecognized example of poliautoimmunity.","volume":"38","author":"Mart\u00edn-Nares","year":"2019","journal-title":"Clin Rheumatol"},{"key":"R5-20250131","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/rheumatology\/kev199","article-title":"Inflammatory bowel diseases in anti-neutrophil cytoplasmic antibody-associated vasculitides: 11 retrospective cases from the French Vasculitis Study Group.","volume":"54","author":"Humbert","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"R6-20250131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/mrcr\/rxad056","article-title":"Overlapping systemic lupus erythematosus, seropositive erosive rheumatoid arthritis, and ANCA-associated vasculitis: a case report and literature review.","volume":"8","author":"Reesor","year":"2023","journal-title":"Mod Rheumatol Case Rep"},{"key":"R7-20250131","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1442-9071.2004.00853.x","article-title":"Clinical case notes. Churg\u2013Strauss syndrome presenting with conjunctival nodules in association with Candida albicans and ankylosing spondylitis.","volume":"32","author":"Ooi","year":"2004","journal-title":"Clin Experiment Ophthalmol"},{"key":"R8-20250131","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10067-015-3134-4","article-title":"Etanercept treatment-related c-ANCA-associated large vessel vasculitis.","volume":"35","author":"Ginsberg","year":"2016","journal-title":"Clin Rheumatol"},{"key":"R9-20250131","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.revmed.2014.09.001","article-title":"Rhumatisme psoriasique au cours d\u2019un traitement par rituximab pour une polyang\u00e9\u00efte avec granulomatose: une nouvelle r\u00e9action paradoxale?","volume":"36","author":"Aussy","year":"2015","journal-title":"La Revue de M\u00e9decine Interne"},{"key":"R10-20250131","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1007\/s10067-021-05612-y","article-title":"ANCA-associated vasculitis in a patient with enteropathic spondyloarthritis: a case report and literature review.","volume":"40","author":"Guimar\u00e3es","year":"2021","journal-title":"Clin Rheumatol"},{"key":"R11-20250131","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/art.41565","article-title":"Spondylitis as a rare manifestation of granulomatosis with polyangiitis.","volume":"73","author":"Busch","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"R12-20250131","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/rheumatology\/kez133","article-title":"Th17 cells: do regulatory B-cells (Breg) take control in ANCA-vasculitis?","volume":"58","author":"Dolff","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"R13-20250131","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1007\/s12325-022-02240-z","article-title":"Levels of peripheral Th17 cells and Th17-related cytokines in patients with ankylosing spondylitis: a meta-analysis.","volume":"39","author":"Su","year":"2022","journal-title":"Adv Ther"},{"key":"R14-20250131","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cyto.2014.10.005","article-title":"Predominance of PR3 specific immune response and skewed TH17 vs. T-regulatory milieu in active granulomatosis with polyangiitis.","volume":"71","author":"Rani","year":"2015","journal-title":"Cytokine"},{"key":"R15-20250131","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.autrev.2018.08.006","article-title":"Th17 cells in renal inflammation and autoimmunity.","volume":"18","author":"Dolff","year":"2019","journal-title":"Autoimmun Rev"},{"key":"R16-20250131","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s13023-020-01621-3","article-title":"French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides).","volume":"15","author":"Terrier","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"R17-20250131","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/rheumatology\/kez071","article-title":"Orbital mass in ANCA-associated vasculitides: data on clinical, biological, radiological and histological presentation, therapeutic management, and outcome from 59 patients.","volume":"58","author":"Durel","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"R18-20250131","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2147\/OARRR.S149373","article-title":"Systematic review of the role of rituximab in treatment of antineutrophil cytoplasmic autoantibody-associated vasculitis, hepatitis C virus-related cryoglobulinemic vasculitis, Henoch\u2013Sch\u00f6nlein purpura, ankylosing spondylitis, and Raynaud\u2019s phenomenon.","volume":"9","author":"Taha","year":"2017","journal-title":"Open Access Rheumatol"},{"key":"R19-20250131","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/art.27383","article-title":"Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial.","volume":"62","author":"Song","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R20-20250131","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1136\/ard.2008.107102","article-title":"Rituximab in the spondyloarthropathies: data of eight patients followed up in the French Autoimmunity and Rituximab (AIR) registry: Table 1.","volume":"69","author":"Nocturne","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R21-20250131","first-page":"1","article-title":"The efficacy and safety of rituximab in a patient with rheumatoid spondylitis.","volume":"2013","author":"Kobak","year":"2013","journal-title":"Case Rep Rheumatol"},{"key":"R22-20250131","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1093\/rheumatology\/ken362","article-title":"The use of rituximab to treat a patient with ankylosing spondylitis and hepatitis B.","volume":"47","author":"Rodriguez-Escalera","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"R23-20250131","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.3899\/jrheum.110132","article-title":"Marked reduction of sacroiliac joint inflammation on magnetic resonance imaging in a patient with ankylosing spondylitis after rituximab treatment: Figure 1.","volume":"38","author":"Huang","year":"2011","journal-title":"J Rheumatol"},{"key":"R24-20250131","doi-asserted-by":"crossref","first-page":"143","DOI":"10.12659\/AJCR.900563","article-title":"Rituximab can induce remission in a patient with ankylosing spondylitis who failed anti-TNF-\u03b1 agent.","volume":"18","author":"AlDhaheri","year":"2017","journal-title":"Am J Case Rep"},{"key":"R25-20250131","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/annrheumdis-2020-217159","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.","volume":"79","author":"Gossec","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"R26-20250131","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/acr.24025","article-title":"2019 Update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis.","volume":"71","author":"Ward","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R27-20250131","doi-asserted-by":"crossref","first-page":"103018","DOI":"10.1016\/j.autrev.2021.103018","article-title":"Current clinical and therapeutic approach to tumour-like mass lesions in granulomatosis with polyangiitis.","volume":"21","author":"Padoan","year":"2022","journal-title":"Autoimmun Rev"},{"key":"R28-20250131","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/acr.22311","article-title":"Effectiveness of rituximab for the otolaryngologic manifestations of granulomatosis with polyangiitis (Wegener\u2019s): RTX for ENT manifestations of GPA.","volume":"66","author":"Lally","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041366","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T20:01:25Z","timestamp":1738353685000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041366","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]}}}